Blog Posts by Date: Sep 2017


2018 PAMA Pricing Draft: How to Take Action

  • September 25, 2017

As XIFIN predicted, the PAMA reporting exercise has resulted in significant proposed laboratory fee cuts. In fact, the multi-year decrease for the top 20 laboratory tests is 28%--4% higher than the 24% projected by XIFIN's analysis using a "weighted average" calculation. Now that the rates have been posted and the commentary period is open, it’s...

Read



Frost & Sullivan Recognizes XIFIN as a Revenue Cycle Management Company of the Year

  • September 21, 2017

We are proud to be named Frost & Sullivan's 2017 North American Revenue Cycle Management Company of the Year in the diagnostic laboratory segment. This award is based on a 10-step process to assess companies for best practices, visionary innovation and performance, and customer impact. Frost & Sullivan recognizes XIFIN based on our...

Read



TripleTree iAwards Finalist

  • September 15, 2017

TripleTree, LLC, a strategic advisor to innovative healthcare technology and services companies, announced XIFIN as a finalist for the 2017 TripleTree iAwards. Since 1997, TripleTree has advised and invested in some of the most innovative, high-growth businesses in healthcare. XIFIN is being recognized as a TripleTree iAwards finalist for our...

Read



XIFIN Celebrates 20 Years

  • September 11, 2017

This year marks the 20th anniversary of the founding of XIFIN; Chief Executive Officer Lâle White recently shared her memories of the past two decades as well as her vision for the future. From the get-go, we created XIFIN to provide innovative software and services to enable better informed decisions in the laboratory environment. Then, as now...

Read